Free Trial

BioLife Solutions (BLFS) Competitors

BioLife Solutions logo
$27.32 -0.41 (-1.48%)
Closing price 10/17/2025 04:00 PM Eastern
Extended Trading
$27.31 -0.01 (-0.04%)
As of 10/17/2025 05:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BLFS vs. BLCO, GKOS, TMDX, SLNO, NVST, LIVN, WRBY, INSP, EYE, and LQDA

Should you be buying BioLife Solutions stock or one of its competitors? The main competitors of BioLife Solutions include Bausch + Lomb (BLCO), Glaukos (GKOS), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), National Vision (EYE), and Liquidia Technologies (LQDA). These companies are all part of the "medical equipment" industry.

BioLife Solutions vs. Its Competitors

Bausch + Lomb (NYSE:BLCO) and BioLife Solutions (NASDAQ:BLFS) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability.

11.1% of Bausch + Lomb shares are held by institutional investors. Comparatively, 93.2% of BioLife Solutions shares are held by institutional investors. 0.8% of Bausch + Lomb shares are held by company insiders. Comparatively, 2.2% of BioLife Solutions shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, BioLife Solutions had 10 more articles in the media than Bausch + Lomb. MarketBeat recorded 11 mentions for BioLife Solutions and 1 mentions for Bausch + Lomb. BioLife Solutions' average media sentiment score of 0.30 beat Bausch + Lomb's score of 0.30 indicating that BioLife Solutions is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bausch + Lomb
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BioLife Solutions
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Bausch + Lomb has a beta of 0.63, suggesting that its stock price is 37% less volatile than the S&P 500. Comparatively, BioLife Solutions has a beta of 1.95, suggesting that its stock price is 95% more volatile than the S&P 500.

Bausch + Lomb presently has a consensus price target of $15.70, suggesting a potential upside of 4.77%. BioLife Solutions has a consensus price target of $31.29, suggesting a potential upside of 14.52%. Given BioLife Solutions' stronger consensus rating and higher possible upside, analysts plainly believe BioLife Solutions is more favorable than Bausch + Lomb.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch + Lomb
2 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.08
BioLife Solutions
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67

BioLife Solutions has lower revenue, but higher earnings than Bausch + Lomb. BioLife Solutions is trading at a lower price-to-earnings ratio than Bausch + Lomb, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch + Lomb$4.79B1.11-$317M-$0.78-19.21
BioLife Solutions$93.47M14.00-$20.18M-$0.12-227.67

BioLife Solutions has a net margin of -5.39% compared to Bausch + Lomb's net margin of -5.58%. Bausch + Lomb's return on equity of 2.33% beat BioLife Solutions' return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch + Lomb-5.58% 2.33% 1.12%
BioLife Solutions -5.39%0.16%0.14%

Summary

BioLife Solutions beats Bausch + Lomb on 12 of the 16 factors compared between the two stocks.

Get BioLife Solutions News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLFS vs. The Competition

MetricBioLife SolutionsMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.33B$10.71B$6.09B$10.49B
Dividend YieldN/A1.89%5.73%4.80%
P/E Ratio-227.6519.6784.7527.11
Price / Sales14.0031.15519.29179.59
Price / Cash226.3525.0337.1661.22
Price / Book3.633.4112.246.52
Net Income-$20.18M$210.63M$3.33B$276.84M
7 Day Performance1.94%0.03%1.19%1.95%
1 Month Performance3.96%-1.38%6.18%2.21%
1 Year Performance15.62%-9.70%59.89%34.06%

BioLife Solutions Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLFS
BioLife Solutions
2.4146 of 5 stars
$27.32
-1.5%
$31.29
+14.5%
+18.1%$1.33B$93.47M-227.65440Positive News
Insider Trade
BLCO
Bausch + Lomb
1.6369 of 5 stars
$14.87
+3.8%
$15.70
+5.6%
-28.4%$5.07B$4.79B-19.0613,500
GKOS
Glaukos
4.4096 of 5 stars
$83.11
+0.7%
$116.92
+40.7%
-32.2%$4.73B$383.48M-50.37780
TMDX
TransMedics Group
3.381 of 5 stars
$111.71
+4.1%
$127.18
+13.8%
-7.5%$3.66B$441.54M57.88210Analyst Forecast
SLNO
Soleno Therapeutics
4.1441 of 5 stars
$64.27
+0.8%
$115.92
+80.4%
+22.4%$3.39BN/A-15.5230
NVST
Envista
4.1569 of 5 stars
$19.23
+0.9%
$21.08
+9.6%
+9.4%$3.17B$2.51B60.1012,300News Coverage
Analyst Revision
LIVN
LivaNova
2.8907 of 5 stars
$51.78
+2.2%
$59.71
+15.3%
+1.0%$2.77B$1.25B-13.312,900
WRBY
Warby Parker
2.5907 of 5 stars
$22.17
-0.4%
$24.75
+11.7%
+34.4%$2.34B$821.35M-316.613,780Positive News
INSP
Inspire Medical Systems
4.8923 of 5 stars
$77.57
+3.2%
$150.50
+94.0%
-60.4%$2.22B$802.80M44.841,246News Coverage
Analyst Forecast
Analyst Revision
EYE
National Vision
2.6506 of 5 stars
$26.37
+3.2%
$24.73
-6.2%
+157.1%$2.02B$1.82B-146.5013,411Positive News
Analyst Upgrade
LQDA
Liquidia Technologies
3.5721 of 5 stars
$23.77
+2.5%
$32.38
+36.2%
+96.2%$2.00B$14M-13.9850Trending News
Insider Trade
Gap Down

Related Companies and Tools


This page (NASDAQ:BLFS) was last updated on 10/18/2025 by MarketBeat.com Staff
From Our Partners